SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-018863
Filing Date
2023-09-13
Accepted
2023-09-13 21:14:00
Documents
2
Period of Report
2023-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4177
2 EX-24 DOCUMENT attachment1.htm EX-24 3903
  Complete submission text file 0000899243-23-018863.txt   9601
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MAGENTA THERAPEUTICS, INC. 100 TECHNOLOGY SQUARE, 5TH FLOOR CAMBRIDGE MA 02139
Business Address
McGeorge Anne (Reporting) CIK: 0001779934 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 231253911